ERBB2 and breast carcinoma: Breast cancer exhibits significant heterogeneity, manifesting substantial variations both within tumors and among different tumor types, and three major biomarkers known to be differentially expressed in most breast cancer types are estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)2,3.